Adherex Technologies (FENC) News Today $9.93 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$9.93 0.00 (0.00%) As of 05/22/2026 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock FENC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period What is HC Wainwright's Estimate for FENC Q3 Earnings?May 25 at 1:28 AM | marketbeat.comAdherex Technologies' PEDMARK push targets larger AYA market after record quarterMay 23 at 11:51 PM | msn.comAdherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record QuarterMay 23 at 10:04 AM | marketbeat.comHC Wainwright Issues Positive Forecast for Adherex Technologies (NASDAQ:FENC) Stock PriceMay 23 at 3:37 AM | americanbankingnews.comFennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual MeetingMay 21, 2026 | globenewswire.comAdherex Technologies Inc. (NASDAQ:FENC) Given Consensus Rating of "Moderate Buy" by AnalystsMay 21, 2026 | americanbankingnews.comFennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 18, 2026 | globenewswire.comWall Street Zen Upgrades Adherex Technologies (NASDAQ:FENC) to Strong-BuyMay 16, 2026 | americanbankingnews.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2026 Earnings Call TranscriptMay 15, 2026 | insidermonkey.comDo options traders know something about Adherex Technologies stock we don't?May 14, 2026 | msn.comFennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comAdherex Technologies Q1 Earnings Call HighlightsMay 14, 2026 | marketbeat.comFennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 14, 2026 | globenewswire.comFennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026May 7, 2026 | globenewswire.comAdherex Technologies (FENC) Expected to Announce Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comAdherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,781 SharesMay 2, 2026 | insidertrades.comInsider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,781 Shares of StockMay 1, 2026 | marketbeat.comAdherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by AnalystsApril 26, 2026 | marketbeat.comFennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer CenterApril 7, 2026 | globenewswire.comFennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 31, 2026 | globenewswire.comFennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call TranscriptMarch 24, 2026 | seekingalpha.comFennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 24, 2026 | globenewswire.comFennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026March 18, 2026 | globenewswire.comFennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer InstituteMarch 4, 2026 | globenewswire.comRosty Raykov Sells 10,349 Shares of Adherex Technologies (NASDAQ:FENC) StockFebruary 3, 2026 | insidertrades.comInsider Selling: Adherex Technologies (NASDAQ:FENC) Major Shareholder Sells 1,000,000 Shares of StockDecember 30, 2025 | insidertrades.comSouthpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)December 26, 2025 | globenewswire.comFennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026December 21, 2025 | seekingalpha.comFennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell TumorsDecember 9, 2025 | globenewswire.comFennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing LossDecember 2, 2025 | globenewswire.comFennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare ConferenceNovember 26, 2025 | globenewswire.comAdherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 19,341 SharesNovember 21, 2025 | insidertrades.comAdherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 85,918 SharesNovember 18, 2025 | insidertrades.comFennec Pharmaceuticals Announces Closing of Offering of Common SharesNovember 17, 2025 | globenewswire.comFennec Pharmaceuticals Announces Private Offering of Common Shares in CanadaNovember 13, 2025 | globenewswire.comFennec Pharmaceuticals Announces Pricing of Offering of Common SharesNovember 13, 2025 | globenewswire.comFennec Pharmaceuticals Announces Proposed Offering of Common SharesNovember 13, 2025 | globenewswire.comAdherex Technologies (NASDAQ:FENC) Director Chris Rallis Sells 1,775 SharesOctober 15, 2025 | insidertrades.comSouthpoint Capital Advisors Lp Sells 19,605 Shares of Adherex Technologies (NASDAQ:FENC) StockOctober 10, 2025 | insidertrades.comInsider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,000 Shares of StockOctober 7, 2025 | insidertrades.comFennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comFennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 14, 2025 | globenewswire.comFennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025August 11, 2025 | globenewswire.comInsider Selling: Adherex Technologies Inc. (NASDAQ:FENC) Director Sells 10,000 Shares of StockAugust 6, 2025 | insidertrades.comRecent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's WhyJuly 15, 2025 | msn.comFennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $77,800.00 in StockJune 7, 2025 | insidertrades.comInsider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC)June 6, 2025 | gurufocus.comFennec Pharmaceuticals Approves Proposals at Shareholder MeetingJune 3, 2025 | tipranks.comFennec Announces Results of Annual MeetingJune 3, 2025 | globenewswire.comFennec Pharmaceuticals at BioConnect: Strategic Moves and Market ExpansionMay 21, 2025 | investing.com Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FENC Media Mentions By Week FENC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FENC News Sentiment▼-0.270.47▲Average Medical News Sentiment FENC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FENC Articles This Week▼142▲FENC Articles Average Week Get the Latest News and Ratings for FENC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Adherex Technologies and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LB Pharmaceuticals News MeiraGTx News Xencor News Pharming Group News Annexon News Janux Therapeutics News Sana Biotechnology News Oric Pharmaceuticals News Vor Biopharma News Theravance Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FENC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
